VeriMomkaempferol rhamnoside est-il sûr pendant la grossesse ?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for kaempferol 3‑rhamnoside (Afzelin, CAS 482-39-3). ECHA substance information shows only company notifications for irritation endpoints (no H360/H361 harmonised classification). Peer‑reviewed literature for this compound reports pharmacology/toxicity studies (neuroprotective, metabolic) but no reproductive or teratology data, so there is no evidence of reproductive hazard. Low dermal/systemic absorption is expected for a polar flavonol glycoside in topical use, so exposure from normal cosmetic topical use is judged low but measurable. Sources: ECHA substance page, PubChem entry, PubMed studies.
Related ingredients
Frequently asked questions
- kaempferol rhamnoside est-il sûr pendant la grossesse ?
- No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for kaempferol 3‑rhamnoside (Afzelin, CAS 482-39-3). ECHA substance information shows only company notifications for irritation endpoints (no H360/H361 harmonised classification). Peer‑reviewed literature for this compound reports pharmacology/toxicity studies (neuroprotective, metabolic) but no reproductive or teratology data, so there is no evidence of reproductive hazard. Low dermal/systemic absorption is expected for a polar flavonol glycoside in topical use, so exposure from normal cosmetic topical use is judged low but measurable. Sources: ECHA substance page, PubChem entry, PubMed studies.
- kaempferol rhamnoside est-il sûr pendant l'allaitement ?
- No data indicate reproductive or lactation-specific toxicity or endocrine disruption for afzelin. With low expected dermal absorption for the glycoside, maternal systemic exposure from cosmetic topical use would likely be low; therefore transfer to breastmilk is unlikely but not studied.
- kaempferol rhamnoside est-il sûr pour la peau de bébé ?
- No infant-specific safety or developmental toxicity data were found. The compound is a flavonol glycoside (polar) and not known to be a developmental toxicant; hazard is therefore scored 0. Because infant skin has an immature barrier and higher surface‑area‑to‑weight, exposure score is increased by +1 relative to adults (adult e=1 → infant e=2) to reflect higher potential per‑kg absorption if applied to baby skin.
- Comment VeriMom évalue-t-il kaempferol rhamnoside ?
- VeriMom évalue kaempferol rhamnoside à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à kaempferol rhamnoside pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à kaempferol rhamnoside basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.